Gender, estrogen, and NOS: cautions about generalizations.
Miller
V M
VM
D000818:Animals; D002318:Cardiovascular Diseases / Q000201:enzymology / Q000503:physiopathology*; D004967:Estrogens / Q000502:physiology*; D005260:Female; D020249:Hormone Replacement Therapy; D006801:Humans; D007527:Isoenzymes / Q000502:physiology*; D008252:Macaca fascicularis; D008297:Male; D008597:Menstrual Cycle / Q000502:physiology*; D009504:Neutrophils / Q000201:enzymology*; D009569:Nitric Oxide / Q000502:physiology*; D019001:Nitric Oxide Synthase / Q000502:physiology*; D052248:Nitric Oxide Synthase Type I; D011817:Rabbits; D020849:Raloxifene Hydrochloride / Q000494:pharmacology / Q000627:therapeutic use; D011960:Receptors, Estrogen / Q000187:drug effects / Q000502:physiology; D012727:Sex Characteristics; D013045:Species Specificity; D014189:Transsexualism / Q000201:enzymology / Q000503:physiopathology
D004967:Estrogens; D007527:Isoenzymes; D011960:Receptors, Estrogen; D009569:Nitric Oxide; D020849:Raloxifene Hydrochloride; C496320:NOS1 protein, human; D019001:Nitric Oxide Synthase; D052248:Nitric Oxide Synthase Type I